Skip to main content
. 2020 Aug 31;21(17):6298. doi: 10.3390/ijms21176298
Amyloid Beta peptide 1-42
AD Alzheimer’s disease
CSF Cerebrospinal fluid
cf-mtDNA Cell-free mitochondrial DNA
CJD Creutzfeldt-Jakob disease
dPCR Digital Polymerase Chain Reaction
ND-Ctrl Control patients diagnosed with neurological diseases without dementia
rpAD Alzheimer’s disease of rapid clinical progression
spAD Alzheimer’s disease of slow clinical progression
p-tau Phosphorylated tau protein
t-tau Total amount of tau protein